Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02918630 · ClinicalTrials.gov registry record · NA
E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia
A NA study of Tobacco Smoking, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT02918630: Completed NA study of Tobacco Smoking, sponsored by The University of Texas Health Science Center, Houston.
NCT02918630 is a NA study of Tobacco Smoking that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 7 participants, below the 477-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02918630, a NA study of Tobacco Smoking, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess if access to an electronic nicotine delivery device, or e-cigarette, in addition to nicotine patch (21 mg) can help reduce cigarette smoking among individuals diagnosed with schizophrenia compared to nicotine patch alone.
Conditions Studied
Interventions
- DRUG Nicotine Patch
- DRUG E-cigarette
Study Locations (1)
Texas
- University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-08 |
| Phase | NA |
What the finished NCT02918630 record still lists
NCT02918630 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 477-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Tobacco Smoking appearing as the primary indexed condition, and to 2 interventions - of which Nicotine Patch is the first listed.
NCT02918630 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02918630 about?
NCT02918630 is a clinical study titled "E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia". The purpose of this study is to assess if access to an electronic nicotine delivery device, or e-cigarette, in addition to nicotine patch (21 mg) can help reduce cigarette smoking among individuals diagnosed with schizophrenia compared to nicotine patch alone.
What is the current status of trial NCT02918630?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2016-10. Estimated completion is 2017-08.
What conditions does trial NCT02918630 study?
This clinical trial studies the following conditions: Tobacco Smoking.
What interventions are being tested in trial NCT02918630?
The interventions under investigation include: Nicotine Patch (DRUG), E-cigarette (DRUG).
Who is sponsoring clinical trial NCT02918630?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02918630 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02918630's enrollment target sits among peer trials
7 39th of 38 the lowest of 38 other Tobacco Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
Development of a Smoking Cessation Video Series
RECRUITING · NA
-
Trauma-Informed Care for Smoking Cessation for Pregnancy
RECRUITING · NA
-
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
RECRUITING · NA
-
Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults
RECRUITING · NA
-
CONNECT Cancer Survivors With Tobacco Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia